Adagio Pauses FDA Emergency Use Request For Its COVID-19 Therapy
Adagio Therapeutics Inc (NASDAQ:ADGI) provided an update on the anticipated timing for its Emergency Use Authorization (EUA) request for adintrevimab (ADG20)…
51 Biggest Movers From Yesterday
Gainers
Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64.
Mid-Afternoon Market Update: Dow Drops 100 Points; Adagio Therapeutics Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 100 points on Wednesday.
Mid-Day Market Update: Crude Oil Surges 3%; Revelation Biosciences Shares Plunge
U.S. stocks traded lower midway through trading following the release of GDP data.
35 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares jumped 82.6% to $4.71 after the company reported a year over year increase in Q4 sales results and issued Q1 sales guidance above analyst estimates.
Adagio’s COVID-19 Antibody Meets Primary Goals Across Pre & Post-Exposure Prophylaxis, Treatment
Adagio Therapeutics Inc’s (NASDAQ:ADGI) Phase 2/3 trials evaluating 300 mg adintrevimab (ADG20) as pre-and-post-exposure prophylaxis (EVADE) and treatment (STAMP)…